Zimmer Biomet Holdings Inc (NYSE:ZBH)
| 117.81 Delayed Data As of May 23 |  +0.02 / +0.02%Today’s Change | 95.63 Today|||52-Week Range 133.21 | +14.16% Year-to-Date |
Latest ZBH News | Press Releases
| Goldman Sachs Rates Health Care Stocks May 17 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 117.79 |
| Today’s open | 117.99 |
| Day’s range | 117.28 - 118.29 |
| Volume | 1,257,182 |
| Average volume (3 months) | 1,289,285 |
| Market cap | $23.8B |
| Dividend yield | 0.81% |
Data as of 4:01pm ET, 05/23/2017
Growth & Valuation
| Earnings growth (last year) | +96.10% |
| Earnings growth (this year) | +7.33% |
| Earnings growth (next 5 years) | +9.90% |
| Revenue growth (last year) | +28.11% |
| P/E ratio | 48.3 |
| Price/Sales | 2.72 |
| Price/Book | 2.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCRC R Bard Inc | +1.08 | +0.35% |
| BSXBoston Scientific Co... | -0.13 | -0.49% |
| TFXTeleflex Inc | +0.86 | +0.43% |
| WSTWest Pharmaceutical ... | -0.28 | -0.29% |
Data as of 4:02pm ET, 05/23/2017
Financials
| Next reporting date | July 27, 2017 |
| EPS forecast (this quarter) | $2.11 |
| Annual revenue (last year) | $7.7B |
| Annual profit (last year) | $305.9M |
| Net profit margin | 3.98% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director David C. Dvorak |
Senior VP-Global Operations & Logistics Adrian Furey |
Corporate headquarters Warsaw, Indiana |
Forecasts
